Age-related conversion to secondary progression in relapsing-remitting multiple sclerosis

被引：0
作者：
Bosca, I.
Casanova, B.
Pascual-Lozano, A.
Magraner, M.
Coret, F.
机构：
[1] Hosp Univ Fe, Valencia, Spain
[2] Hosp Clinico Universitario, Valencia, Spain
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [31] Circulatory miRNAs and multiple sclerosis: possible biomarkers for conversion from relapsing-remitting to secondary progressive form
    Agostini, Simone
    Mancuso, Roberta
    Citterio, Lorenzo Agostino
    Caputo, Domenico
    Clerici, Mario
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 722 - 723
  • [32] Metabolomic profiling in relapsing-remitting multiple sclerosis
    Patel, Y.
    Vingara, L.
    Li, Y.
    Yu, H. J.
    Wagshul, M.
    Pelczer, I.
    Christodoulou, C.
    Melville, P.
    Maletic-Savatic, M.
    Krupp, L.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S80 - S80
  • [33] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2011, 25 : 239 - 249
  • [34] Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis
    Filippi, M
    Wolinsky, JS
    Sormani, MP
    Comi, G
    NEUROLOGY, 2001, 56 (03) : 422 - 423
  • [35] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [36] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [37] Intravenous immunoglobulin in relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    SarovaPinhas, I
    Achiron, R
    Gabbay, U
    Rotstein, Z
    Noy, S
    INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 289 - 293
  • [38] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [39] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [40] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
12345